Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation

被引：25
|
作者：
Laryea, Marie A. [2 ]
Watt, Kymberly D. [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Dalhousie Univ, Multiorgan Transplant Program, Halifax, NS, Canada
来源：
LIVER TRANSPLANTATION | 2012年 / 18卷 / 05期
关键词：
B IMMUNE GLOBULIN; HBV-RELATED CIRRHOSIS; TERM-FOLLOW-UP; VIRUS RECURRENCE; ADEFOVIR DIPIVOXIL; SURFACE-ANTIGEN; POSITIVE GRAFTS; LOW-RISK; LAMIVUDINE; PROPHYLAXIS;
D O I：
10.1002/lt.23408
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The reinfection of the hepatic allograft with hepatitis B virus and hepatitis C virus can have important sequelae that result in poor long-term patient and graft survival. Although a response to treatment with antiviral medications can improve these outcomes, not all patients tolerate these medications or experience viral eradication. Avoiding reinfection of the graft is the most effective means of improving the long-term outcomes for these patient populations. This review is focused on the prevention of viral hepatitis reinfection after liver transplantation. Liver Transpl, 2012. (C) 2012 AASLD.
引用
收藏
页码：514 / 523
页数：10
相关论文
共 50 条
  • [31] RECURRENT HCV HEPATITIS AFTER LIVER-TRANSPLANTATION
    BELLI, LS
    RONDINARA, GF
    ROMANI, F
    ALBERTI, A
    DECARLIS, L
    IDEO, G
    BELLI, L
    LANCET, 1993, 341 (8841): : 378 - 379
  • [32] Management of recurrent hepatitis C after liver transplantation
    Teixeira, R
    Papatheodoridis, GV
    Burroughs, AK
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (03) : 159 - 168
  • [33] Recurrent autoimmune hepatitis after orthotopic liver transplantation
    González-Koch, A
    Czaja, AJ
    Carpenter, HA
    Roberts, SK
    Charlton, MR
    Porayko, MK
    Rosen, CB
    Wiesner, RH
    LIVER TRANSPLANTATION, 2001, 7 (04) : 302 - 310
  • [34] IMMUNOPROPHYLAXIS WITH HEPATITIS-B IMMUNOGLOBULIN AFTER LIVER-TRANSPLANTATION - AN ECONOMICAL APPROACH
    BARUCH, Y
    BENPORATH, E
    ENAT, R
    JOURNAL OF HEPATOLOGY, 1994, 20 (01) : 153 - 154
  • [35] NITAZOXANIDE FOR THE PREVENTION OF RECURRENT HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION: A PILOT STUDY
    Asrani, Sumeet K.
    Anderson, Stacy
    Wilson, Jennie
    Myhre, Laura J.
    Heimbach, Julie
    Kremers, Walter K.
    Rosen, Charles B.
    Therneau, Terry M.
    Kim, W. Ray
    HEPATOLOGY, 2010, 52 (04) : 874A - 874A
  • [36] Long-term immunoprophylaxis for hepatitis B virus reinfection after liver transplantation
    Lee, WC
    Jeng, LBB
    Wang, CC
    Chen, MF
    Chien, RN
    Chiu, CT
    Ling, DY
    Liaw, YF
    Chang, CH
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1699 - 1700
  • [37] Active Immunoprophylaxis With Hepatitis B Virus (HBV) Vaccination Is Not an Effective Strategy for Prevention of HBV Recurrence after Liver Transplantation.
    Turan, Ilker
    Mut, Deniz
    Sozbilen, Murat
    Erensoy, Selda
    Gunsar, Fulya
    Ersoz, Galip
    Akarca, Ulus S.
    Karasu, Zeki
    LIVER TRANSPLANTATION, 2014, 20 : S275 - S275
  • [38] Cost comparison of hepatitis B immune globulin (HBIG) administered intramuscularly or intravenously as immunoprophylaxis for recurrent hepatitis B after orthotopic liver transplantation (OLT).
    Sievers, TM
    Colquhoun, SD
    Arnaout, WS
    Vierling, JM
    HEPATOLOGY, 1999, 30 (04) : 241A - 241A
  • [39] Prevention of hepatitis B recurrence after liver transplantation
    Seehofer, D
    Berg, T
    TRANSPLANTATION, 2005, 80 (01) : S120 - S124
  • [40] Prevention of hepatitis B after liver transplantation.
    Yi, NJ
    Suh, KS
    Chang, SH
    Choi, SH
    Kwon, CH
    Lee, KU
    HEPATOLOGY, 2003, 38 (04) : 537A - 537A
12345